Weight-loss drugs could tackle Alzheimer's—study
A new study has found comprehensive evidence that "weight-loss" GLP-1 receptor agonists such as semaglutide are effective in tackling the biological drivers of Alzheimer's disease. The study, published in the journal Molecular ...
38 minutes ago
0
0









